Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.
Progress in multiple sclerosis research in the last year.
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Systematic approaches to central nervous system myelin.
Autoimmune myelopathies.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
High dose naltrexone for dyskinesias induced by levodopa.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Complementary and alternative medicine in multiple sclerosis.
Study Suggests Targeting B Cells May Help with MS
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
High dose thiamine improves fatigue in multiple sclerosis.
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Cognitive impairment and cortical degeneration in neuromyelitis optica.
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
Animal Models in Neurology: Drawbacks and Opportunities.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Receptos provides update on progress of lead product candidate RPC1063
Pages
« first
‹ previous
…
148
149
150
151
152
153
154
155
156
…
next ›
last »